|
1
|
Sardiñas N, Marcos R, Pestaña EM, Vargas
J, Chi-Ramírez D, Rojas E, Esteban EM and Zarrabeitía L: Tumors of
the posterior fossa in children. Rev Neurol. 28:1153–1158. 1999.(In
Spanish). PubMed/NCBI
|
|
2
|
Packer RJ, Cogen P, Vezina G and Rorke LB:
Medulloblastoma: Clinical and biologic aspects. Neuro Oncol.
1:232–250. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan XY: Angiogenesis: A promising strategy
for tumor therapy. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao.
26:180–193. 2010.(In Chinese).
|
|
4
|
Lohela M, Bry M, Tammela T and Alitalo K:
VEGFs and receptors involved in angiogenesis versus
lymphangiogenesis. Curr Opin Cell Biol. 21:154–165. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roberts E, Cossigny DA and Quan GM: The
role of vascular endothelial growth factor in metastatic prostate
cancer to the skeleton. Prostate Cancer. 2013:4183402013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mao X, Wang T, Liu Y, Irwin MG, Ou JS,
Liao XL, Gao X, Xu Y, Ng KF, Vanhoutte PM and Xia Z:
N-acetylcysteine and allopurinol confer synergy in attenuating
myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in
diabetic rats. PLoS One. 8:e689492013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vimala N, Mittal S, Kumar S, Dadhwal V and
Sharma Y: A randomized comparison of sublingual and vaginal
misoprostol for cervical priming before suction termination of
first-trimester pregnancy. Contraception. 70:117–120. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mende A, Takano H, Kodama Y, Nakamura T,
Umetani K, Fujioka D, Saito Y, Kobayashi T, Kawabata K, Obata JE,
et al: Relation between transcardiac gradient of VEGF and coronary
flow response in humans. Int J Cardiol. 119:156–162. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stumpf C, Jukic J, Yilmaz A, Raaz D,
Schmieder RE, Daniel WG and Garlichs CD: Elevated VEGF-plasma
levels in young patients with mild essential hypertension. Eur J
Clin Invest. 39:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong N, Zhang Z, Huang J, Chen C, Zhang
Z, Jia M, Xiong J, Liu X, Wang F, Cao X, et al: VEGF-expressing
human umbilical cord mesenchymal stem cells, an improved therapy
strategy for Parkinson's disease. Gene Ther. 18:394–402. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim NH, Jung HH, Cha DR and Choi DS:
Expression of vascular endothelial growth factor in response to
high glucose in rat mesangial cells. J Endocrinol. 165:617–624.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li H, Wang Y, Liu F, Lou YL, Deng J and
Cui SP: Dynamic changes of the expression of hypoxia inducible
factor-1α and the target genes miR-210, vascular endothelial growth
factor in the kidney after ischemic-reperfusion injury. Zhong Hua
Shi Yan Wai Ke Za Zhi. 28:2074–2076. 2011.(In Chinese).
|
|
13
|
Cha HS, Bae EK, Koh JH, Chai JY, Jeon CH,
Ahn KS, Kim J and Koh EM: Tumor necrosis factor-alpha induces
vascular endothelial growth factor-C expression in rheumatoid
synoviocytes. J Rheumatol. 34:16–19. 2007.PubMed/NCBI
|
|
14
|
Agrawal R, Pandey P, Jha P, Dwivedi V,
Sarkar C and Kulshreshtha R: Hypoxic signature of microRNAs in
glioblastoma: Insights from small RNA deep sequencing. BMC
Genomics. 15:6862014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu SQ, Yu HC, Gong YZ and Lai NS:
Quantitiative measurement of HLA-B27 mRNA in patients with
ankylosing spondylitis - correlation with clinical activity. J
Rheumatol. 33:1128–1132. 2006.PubMed/NCBI
|
|
16
|
Brahimi-Horn MC, Chiche J and Pouysségur
J: Hypoxia and cancer. J Mol Med (Berl). 85:1301–1307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen AL and Colman H: Glioma biology and
molecular markers. Cancer Treat Res. 163:15–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barai S, Bandopadhayaya GP, Julka PK,
Dhanapathi H, Haloi AK and Seith A: Cerebellar medulloblastoma
presenting with skeletal metastasis. J Postgrad Med. 50:110–112.
2004.PubMed/NCBI
|
|
19
|
Slongo ML, Molena B, Brunati AM, Frasson
M, Gardiman M, Carli M, Perilongo G, Rosolen A and Onisto M:
Functional VEGF and VEGF receptors are expressed in human
medulloblastomas. Neuro Oncol. 9:384–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quero L, Dubois L, Lieuwes NG, Hennequin C
and Lambin P: miR-210 as a marker of chronic hypoxia, but not a
therapeutic target in prostate cancer. Radiother Oncol.
101:203–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng L, He X, Wang Y, Tang Y, Zheng C, Cai
H, Liu J, Wang Y, Fu Y and Yang GY: MicroRNA-210 overexpression
induces angiogenesis and neurogenesis in the normal adult mouse
brain. Gene Ther. 21:37–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lou Y, Gao F, Xie A, Guo F, Deng Z and
Wang Y: MicroRNA-210 modified human umbilical vein endothelial
cells induce capillary formation. Zhongguo Xiu Fu Chong Jian Wai Ke
Za Zhi. 26:587–591. 2012.(In Chinese). PubMed/NCBI
|
|
23
|
Shoji T, Nakasa T, Yamasaki K, Kodama A,
Miyaki S, Niimoto T, Okuhara A, Kamei N, Adachi N and Ochi M: The
effect of intra-articular injection of microRNA-210 on ligament
healing in a rat model. Am J Sports Med. 40:2470–2478. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szabó DR, Luconi M, Szabó PM, Tóth M,
Szücs N, Horányi J, Nagy Z, Mannelli M, Patócs A, Rácz K and Igaz
P: Analysis of circulating microRNAs in adrenocortical tumors. Lab
Invest. 94:331–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alaiti MA, Ishikawa M, Masuda H, Simon DI,
Jain MK, Asahara T and Costa MA: Up-regulation of miR-210 by
vascular endothelial growth factor in ex vivo expanded CD34+ cells
enhances cell-mediated angiogenesis. J Cell Mol Med. 16:2413–2421.
2012. View Article : Google Scholar : PubMed/NCBI
|
